This invention provides fully human monoclonalantibodies that recognize IL-17F and/or the heterodimericIL-17A/IL-17F complex, but do not recognizeIL-17A. The invention further provides methods of usingsuch monoclonal antibodies as a therapeutic, diagnostic,and prophylactic.